Last reviewed · How we verify
NCT06836427
CMTS0929 for Clostridioides Difficile Infection
EARLY_PHASE1 trial testing CMTS0929 in Clostridioides Difficile Infection in 12 participants. Not yet recruiting.
31 January 2030
Quick facts
| Lead sponsor | The Second Hospital of Nanjing Medical University |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 12 |
| Start date | 20 February 2025 |
| Primary completion | 31 January 2030 |
| Estimated completion | 1 July 2030 |
| Sites | 1 location across China |
Drugs / interventions tested
- CMTS0929 — full drug profile →
Conditions studied
- Clostridioides Difficile Infection — all drugs for Clostridioides Difficile Infection →
Sponsor
The Second Hospital of Nanjing Medical University
Who can join
Adults 18 to 75, any sex, with Clostridioides Difficile Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective, open-label, single-arm study to explore the safety and the efficacy of CMTS0929 for patients with Clostridioides difficile infection (CDI).
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06836427
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CMTS0929
Trials testing the same drug.
- NCT06844708 — CMTS0929 for Inflammatory Bowel Disease · EARLY_PHASE1 · not yet recruiting
Other recruiting trials for Clostridioides Difficile Infection
Currently open trials in the same condition.
- NCT07285213 — Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody · Phase 2 · recruiting
- NCT06979609 — Secondary Prevention of Clostridioides Difficile Using Vancomycin · Phase 2, PHASE3 · recruiting
- NCT06859437 — Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain in Nephrology and Transplantati · NA · recruiting
- NCT05330182 — LMN-201 for Prevention of C. Difficile Infection Recurrence · Phase 2, PHASE3 · recruiting
- NCT06788769 — Study of Clostridioides Difficile in Infants · recruiting
Other The Second Hospital of Nanjing Medical University trials
Trials by the same sponsor.
- NCT07331688 — CMTS0515-auWMT for Radiation Enteritis · Phase 1, PHASE2 · active not recruiting
- NCT06839586 — CMTS4520 for Chronic Diarrhoea in Adults · Phase 1, PHASE2 · active not recruiting
- NCT06839599 — CMTS4520-Assisted Washed Microbiota Transplantation for Chronic Diarrhoea in Adults · Phase 1, PHASE2 · not yet recruiting
- NCT06844708 — CMTS0929 for Inflammatory Bowel Disease · EARLY_PHASE1 · not yet recruiting
- NCT06832176 — CMTS4520-Assisted Washed Microbiota Transplantation for Chronic Constipation in Adults · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06836427 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Second Hospital of Nanjing Medical University
- Last refreshed: 20 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06836427.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing